Cargando…
Safety evaluation of human umbilical cord-mesenchymal stem cells in type 2 diabetes mellitus treatment: A phase 2 clinical trial
BACKGROUND: Progressive pancreatic β cell dysfunction is a fundamental aspect of the pathology underlying type 2 diabetes mellitus (T2DM). Recently, mesenchymal stem cell (MSC) transplantation has emerged as a new therapeutic method due to its ability to promote the regeneration of pancreatic β cell...
Autores principales: | Lian, Xiao-Fen, Lu, Dong-Hui, Liu, Hong-Li, Liu, Yan-Jing, Yang, Yang, Lin, Yuan, Xie, Feng, Huang, Cai-Hao, Wu, Hong-Mei, Long, Ai-Mei, Hui, Chen-Jun, Shi, Yu, Chen, Yun, Gao, Yun-Feng, Zhang, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424020/ https://www.ncbi.nlm.nih.gov/pubmed/37583846 http://dx.doi.org/10.12998/wjcc.v11.i21.5083 |
Ejemplares similares
-
Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus
por: Lian, Xiao-Fen, et al.
Publicado: (2022) -
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE
por: Kamen, Diane L, et al.
Publicado: (2022) -
Abstract 14 Umbilical Cord Mesenchymal Stromal/Stem Cells Application for Spasticity Treatment in Multiple Sclerosis
por: Petriv, Taras, et al.
Publicado: (2022) -
Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19
por: Wei, Fengtao, et al.
Publicado: (2021) -
Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study
por: Feng, Ying, et al.
Publicado: (2020)